When Should We Start Sodium-Glucose Co-transporter Inhibitors in Patients with Heart Failure? The Importance of Early Intervention
Eur Cardiol
.
2023 Jun 7:18:e41.
doi: 10.15420/ecr.2022.62.
eCollection 2023.
Authors
Moritake Iguchi
1
,
Hiromichi Wada
2
,
Felipe Martínez
3
,
Koji Hasegawa
2
Affiliations
1
Department of Cardiac Rehabilitation, National Hospital Organization Kyoto Medical Center Kyoto, Japan.
2
Division of Translational Research, National Hospital Organization Kyoto Medical Center Kyoto, Japan.
3
Córdoba National University Córdoba, Argentina.
PMID:
37456773
PMCID:
PMC10345959
DOI:
10.15420/ecr.2022.62
No abstract available
Keywords:
Heart failure; SGLT2 inhibitor; pharmacotherapy.
Publication types
Editorial